(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine Basic information
- Product Name:
- (3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine
- Synonyms:
-
- Tofacitib impurity SM2-G
- (3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine
- cis-1-Benzyl-N,4-diMethylpiperidin-3-aMine
- (3R,4R)-rel-N,4-Dimethyl-1-(phenylmethyl)-3-Piperidinamine
- (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine (rel)
- 3-PiperidinaMine, N,4-diMethyl-1-(phenylMethyl)-, (3R,4R)-rel-
- 3-piperidinaMine, N,4-diMethyl-1-(phenylMethyl)-, (3S,4S)-
- (3S,4S)-(1-Benzyl-4-methyl-piperidin-3-yl)-methyl-amine
- CAS:
- 477600-69-4
- MF:
- C14H22N2
- MW:
- 218.34
- EINECS:
- 1312995-182-4
- Mol File:
- 477600-69-4.mol
More
Less
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine Chemical Properties
- Boiling point:
- 302.6±35.0 °C(Predicted)
- Density
- 1.00±0.1 g/cm3(Predicted)
- storage temp.
- under inert gas (nitrogen or Argon) at 2–8 °C
- pka
- 10.26±0.40(Predicted)
More
Less
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine Usage And Synthesis
Uses
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine is a reagent used in the preparation of substituted pyrrrolipyrimidinamines as Januus kinase inhibitors (CP-352,664), for the treatment of autoimmune diseases and organ transplant rejection.
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amineSupplier
BeiJing Hwrk Chemicals Limted
- Tel
- 0757-86329057 18934348241
- sales4.gd@hwrkchemical.com
Shanghai Boc Chemical Co.,Ltd
- Tel
- 021-34975603-808 18721111801
- sales@bocpharma.com
Tianjin Derchemist Science & Technology Co., Ltd.
- Tel
- 22-58627059 13920586291
- zdcomcon@126.com
Shanghai Coupling Pharmaceutical R&D Co.,Ltd.(Former company is Brother Chemistry)
- Tel
- 021-50106671
S.Z. PhyStandard Bio-Tech. Co., Ltd.
- Tel
- 0755-4000505016 13380397412
- 3001272453@qq.com
More
Less
(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine(477600-69-4)Related Product Information
- 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-
- 2,4-DICHLORO-7H-PYRROLO2,3-DPYRIMIDINE
- (3R,4S)-1-benzyl-N,4-dimethylpiperidin-3-amine
- (3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine
- 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-
- (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride
- Tofacitinib Related Compound 36
- CYANOACETIC ACID-OSU
- N-Hydroxysuccinimide
- Tofacitinib Impurity 2
- N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine
- Tofacitinib Related Compound
- 3-Piperidinamine,4-methyl-1-(phenylmethyl)-,(3R,4R)-rel-
- methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate
- N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- 3-((3S,4S)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile
- Tofacitinib Related Compound 42
- Tofacitinib Related Compound 39